Home/ Stocks/ BCRX

BioCryst Pharmaceuticals Inc

BCRX XNAS

$9.38 +0.12 (+1.29%) ▲ 15-min delayed

Open

$9.50

High

$9.66

Low

$9.23

Volume

4.38M

Market Cap

$2.38B

About BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 435 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$218.25M	$78.39M	$0.31
Q1 2026	$156.41M	$-721,812,000	$-2.98
FY 2025	$874.84M	$263.86M	$1.26
Q3 2025	$159.40M	$12.90M	$0.06

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for BCRX yet. Check out our latest market news or earnings calendar.

Get BCRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on BioCryst Pharmaceuticals Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.